NervGen Pharma Corp. NGEN
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 415.17% | -26.30% | 97.29% | -29.01% | 14.15% |
| Total Receivables | 110.45% | 2.92% | -75.98% | 138.98% | -60.77% |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | -10.10% | 607.11% | 78.32% | 72.19% | -0.53% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -74.66% | 250.08% | -63.41% | 27.26% | 52.71% |
| Total Current Assets | 333.36% | -12.24% | 83.04% | -24.84% | 12.91% |
|
|
|||||
| Total Current Assets | 333.36% | -12.24% | 83.04% | -24.84% | 12.91% |
| Net Property, Plant & Equipment | -- | -- | -- | -- | -- |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -5.16% | -5.13% | -1.78% | -5.21% | 2.14% |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -- | -- | -- | -- | -- |
| Total Assets | 326.92% | -12.12% | 80.30% | -24.34% | 12.61% |
|
|
|||||
| Total Accounts Payable | -30.67% | 50.00% | -28.32% | -2.79% | 7.09% |
| Total Accrued Expenses | -28.29% | 23.83% | -12.37% | 1.42% | 22.38% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -- | -- | -74.48% | -43.50% | -25.66% |
| Total Finance Division Other Current Liabilities | 310.85% | -39.07% | 44.68% | -17.54% | 34.20% |
| Total Other Current Liabilities | 310.85% | -39.07% | 44.68% | -17.54% | 34.20% |
| Total Current Liabilities | 179.89% | -24.22% | 25.14% | -12.09% | 30.13% |
|
|
|||||
| Total Current Liabilities | 179.89% | -24.22% | 25.14% | -12.09% | 30.13% |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | 179.89% | -24.22% | 25.14% | -12.09% | 30.13% |
|
|
|||||
| Common Stock & APIC | 28.04% | 2.90% | 15.64% | 0.20% | 13.07% |
| Retained Earnings | 11.74% | 0.65% | -24.40% | -1.86% | -14.43% |
| Treasury Stock & Other | -15.58% | -4.17% | 81.58% | 0.02% | 8.71% |
| Total Common Equity | 730.84% | 56.56% | 220.07% | -213.62% | -169.66% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 730.84% | 56.56% | 220.07% | -213.62% | -169.66% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 730.84% | 56.56% | 220.07% | -213.62% | -169.66% |
|
|
|||||